Evidence map›Paper›PMID 26069270›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2015

Glycogen synthase kinase 3β inhibition enhanced proliferation, migration and functional re-endothelialization of endothelial progenitor cells in hypercholesterolemia microenvironment.

Bin Cui, Jun Jin, Xiaohan Ding, Mengyang Deng, Shiyong Yu, MingBao Song, Yang Yu, Xiaohui Zhao, Jianfei Chen, Lan Huang

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Bin CuiInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
Jun JinInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
Xiaohan DingInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
Mengyang DengInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
Shiyong YuInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
MingBao SongInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
Yang YuInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
Xiaohui ZhaoInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
Jianfei ChenInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China.
Lan HuangInstitute of Cardiovascular disease of PLA, Xinqiao Hospital, Third military Medical University, Chongqing 400037, People's Republic of China huanglan260@126.com.
Xinqiao Hospital · CNArmy Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypercholesterolemia impairs the quantity and function of endothelial progenitor cell. We hypothesized that glycogen synthase kinase 3β activity is involved in regulating biological function of endothelial progenitor cells in hypercholesterolemia microenvironment. For study, endothelial progenitor cells derived from apolipoprotein E-deficient mice fed with high-fat diet were used. Glycogen synthase kinase 3β activity was interfered with glycogen synthase kinase 3β inhibitor lithium chloride or transduced with replication defective adenovirus vector expressing catalytically inactive glycogen synthase kinase 3β (GSK3β-KM). Functions of endothelial progenitor cells, proliferation, migration, secretion and network formation of endothelial progenitor cells were assessed in vitro. The expression of phospho-glycogen synthase kinase 3β, β-catenin and cyclinD1 in endothelial progenitor cells was detected by Western blot. The in vivo function re-endothelialization and vasodilation were also analyzed by artery injury model transplanted with glycogen synthase kinase 3β-inhibited endothelial progenitor cells. We demonstrated that while the proliferation, migration, network formation as well as VEGF and NO secretion were impaired in apolipoprotein E-deficient endothelial progenitor cells, glycogen synthase kinase 3β inhibition significantly improved all these functions. Apolipoprotein E-deficient endothelial progenitor cells showed decreased phospho-glycogen synthase kinase 3β, β-catenin and cyclinD1 expression, whereas these signals were enhanced by glycogen synthase kinase 3β inhibition and accompanied with β-catenin nuclear translocation. Our in vivo model showed that glycogen synthase kinase 3β inhibition remarkably increased re-endothelial and vasodilation. Taken together, our data suggest that inhibition of glycogen synthase kinase 3β is associated with endothelial progenitor cell biological functions both in vitro and in vivo. It might be an important interference target in hypercholesterolemia microenvironment.

Indexed as

AnimalsBlotting, WesternCell CycleCell MovementCell ProliferationCells, CulturedEndothelial Progenitor CellsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHypercholesterolemiaMaleMiceMice, Inbred C57BLNitric OxideVascular Endothelial Growth Factor AGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, mouseNitric OxideVascular Endothelial Growth Factor AEndothelial progenitor cellendotheliumglycogen synthase kinasehypercholesterolemialithium

Identifiers

PMID26069270
PMCPMC4935338
OpenAlexW2300753157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.